PROMETHEUS BIOSCIENCES, INC. Share-based Payment Arrangement, Expense
PROMETHEUS BIOSCIENCES, INC. reported Share-based Payment Arrangement, Expense of $9.38 million for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2023-05-09
- PROMETHEUS BIOSCIENCES, INC. share-based payment arrangement, expense for the quarter ending 2023-03-31 was $9.38M, a 186.12% increase year-over-year.
- PROMETHEUS BIOSCIENCES, INC. share-based payment arrangement, expense for the quarter ending 2022-12-31 was $6.92M, a 182.10% increase year-over-year.
- PROMETHEUS BIOSCIENCES, INC. share-based payment arrangement, expense for the quarter ending 2022-09-30 was $6.03M, a 3.57% decline year-over-year.
- PROMETHEUS BIOSCIENCES, INC. share-based payment arrangement, expense for the quarter ending 2022-06-30 was $4.64M, a 285.37% increase year-over-year.
- PROMETHEUS BIOSCIENCES, INC. share-based payment arrangement, expense for fiscal 2022 was $20.86M, a 95.01% increase from fiscal 2021.
- PROMETHEUS BIOSCIENCES, INC. share-based payment arrangement, expense for fiscal 2021 was $10.70M, a 1173.57% increase from fiscal 2020.
- PROMETHEUS BIOSCIENCES, INC. share-based payment arrangement, expense for fiscal 2020 was $840.00K.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|
| 2023-03-31 | $9.38M 10-Q · filed 2023-05-09 | $16.30M derived: sum of 2 quarters · filed 2023-05-09 | $22.33M derived: sum of 3 quarters · filed 2023-05-09 | $26.96M derived: sum of 4 quarters · filed 2023-05-09 |
| 2022-12-31 | $6.92M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $12.95M derived: sum of 2 quarters · filed 2023-02-28 | $17.58M derived: sum of 3 quarters · filed 2023-02-28 | $20.86M 10-K · filed 2023-02-28 |
| 2022-09-30 | $6.03M 10-Q · filed 2022-11-09 | $10.66M derived: sum of 2 quarters · filed 2022-11-09 | $13.94M 10-Q · filed 2022-11-09 | $16.39M derived: sum of 4 quarters · filed 2023-05-09 |
| 2022-06-30 | $4.64M 10-Q · filed 2022-08-11 | $7.92M 10-Q · filed 2022-08-11 | $10.37M derived: sum of 3 quarters · filed 2023-05-09 | $16.62M derived: sum of 4 quarters · filed 2023-05-09 |
| 2022-03-31 | $3.28M 10-Q · filed 2023-05-09 | $5.73M derived: sum of 2 quarters · filed 2023-05-09 | $11.98M derived: sum of 3 quarters · filed 2023-05-09 | $13.19M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $2.45M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $8.70M derived: sum of 2 quarters · filed 2023-02-28 | $9.91M derived: sum of 3 quarters · filed 2023-02-28 | $10.70M 10-K · filed 2023-02-28 |
| 2021-09-30 | $6.25M 10-Q · filed 2022-11-09 | $7.45M derived: sum of 2 quarters · filed 2022-11-09 | $8.24M 10-Q · filed 2022-11-09 | $8.57M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $1.20M 10-Q · filed 2022-08-11 | $2.00M 10-Q · filed 2022-08-11 | $2.32M derived: sum of 3 quarters · filed 2023-02-28 | $2.52M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $792.00K 10-Q · filed 2022-05-12 | $1.12M derived: sum of 2 quarters · filed 2023-02-28 | $1.32M derived: sum of 3 quarters · filed 2023-02-28 | $1.49M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $327.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $529.00K derived: sum of 2 quarters · filed 2023-02-28 | $693.00K derived: sum of 3 quarters · filed 2023-02-28 | $840.00K 10-K · filed 2023-02-28 |
| 2020-09-30 | $202.00K 10-Q · filed 2021-11-12 | $366.00K derived: sum of 2 quarters · filed 2021-11-12 | $513.00K 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $164.00K 10-Q · filed 2021-08-11 | $311.00K 10-Q · filed 2021-08-11 | ||
| 2020-03-31 | $147.00K 10-Q · filed 2021-05-13 |